FindTrial
Sign In

Prognostic value of tumor stromal ratio in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter study

Prognostic value of tumor stromal ratio in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter study (TSU-01 study)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034425
Enrollment
Unknown
Registered
2020-07-05
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper tract urothelial carcinoma

Interventions

TSR>50%:Nil
TSR = 50%:Nil

Sponsors

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Aged 18 years and older; (2) RNU performed between the year 2006 and 2017; (3) Disease in the renal pelvis or ureter; predominant urothelial carcinoma histology; (4) Without missing of clinical, pathological or follow-up information. (5) Voluntary participation, the participants himself or his legal representative sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Distant metastasis; (2) History of other malignant tumor; (3) History of neoadjuvant chemotherapy; (4) Patients with previous history of bladder cancer or other urothelial carcinoma; (5) The other condition that is not suitable to participate in this study by the researchers.

Design outcomes

Primary

MeasureTime frame
Overall survival;—

Secondary

MeasureTime frame
Cancer-Specific Survival;Relapse-Free Survival;—

Countries

China

Contacts

Public ContactJian Huang

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

huangj8@mail.sysu.edu.cn+86 13600054833

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026